A Study of AZD4901 in Females With Polycystic Ovary Syndrome

NCT01872078 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

67

Enrollment

INDUSTRY

Sponsor class

Conditions

Polycystic Ovary Syndrome (PCOS), Female Endocrine Disorder

Interventions

DRUG: AZD4901 (oral)
DRUG: Placebo to match AZD4901

Sponsor

AstraZeneca